{
  "openalex_id": "W2626059913",
  "doi": "https://doi.org/10.18632/oncotarget.18520",
  "title": "Preclinical testing of the glycogen synthase kinase-3Î² inhibitor tideglusib for rhabdomyosarcoma",
  "abstract": "// Narendra Bharathy 1 , Matthew N. Svalina 1 , Teagan P. Settelmeyer 1 , Megan M. Cleary 1 , Noah E. Berlow 1 , Susan D. Airhart 2 , Sunny Xiang 2 , James Keck 2 , James B. Hayden 3 , Jack F. Shern 4, 5 , Atiya Mansoor 6 , Melvin Lathara 7 , Ganapati Srinivasa 7 , David M. Langenau 8, 9 and Charles Keller 1 1 Children&rsquo;s Cancer Therapy Development Institute, Beaverton, OR 97005, USA 2 The Jackson Laboratory, Sacramento, CA 95838, USA 3 Department of Orthopedics and Rehabilitation, Oregon Health &amp; Science University, Portland, OR 97239, USA 4 Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA 5 Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA 6 Department of Pathology, Oregon Health &amp; Science University, Portland, OR 97239, USA 7 Omics Data Automation, Beaverton, OR 97005, USA 8 Molecular Pathology, Cancer Center, and Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA 9 Harvard Stem Cell Institute, Cambridge, MA 02129, USA Correspondence to: Narendra Bharathy, email: naren@cc-tdi.org Charles Keller, email: charles@cc-tdi.org Keywords: rhabdomyosarcoma, preclinical testing, patient-derived xenograft, GSK3&beta;, myodifferentiation Received: December 07, 2016&emsp;&emsp;&emsp;&emsp; Accepted: June 01, 2017&emsp;&emsp;&emsp;&emsp; Published: June 16, 2017 ABSTRACT Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. RMS often arise from myogenic precursors and displays a poorly differentiated skeletal muscle phenotype most closely resembling regenerating muscle. GSK3&beta; is a ubiquitously expressed serine-threonine kinase capable of repressing the terminal myogenic differentiation program in cardiac and skeletal muscle. Recent unbiased chemical screening efforts have prioritized GSK3&beta; inhibitors as inducers of myodifferentiation in RMS, suggesting efficacy as single agents in suppressing growth and promoting self-renewal in zebrafish transgenic embryonal RMS (eRMS) models in vivo . In this study, we tested the irreversible GSK3&beta;-inhibitor, tideglusib for in vivo efficacy in patient-derived xenograft models of both alveolar rhabdomyosarcoma (aRMS) and eRMS. Tideglusib had effective on-target pharmacodynamic efficacy, but as a single agent had no effect on tumor progression or myodifferentiation. These results suggest that as monotherapy, GSK3&beta; inhibitors may not be a viable treatment for aRMS or eRMS.",
  "authors": [
    {
      "display_name": "Narendra Bharathy",
      "id": "A5001937049",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210137443",
          "display_name": "Children's Cancer Therapy Development Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Narendra Bharathy"
    },
    {
      "display_name": "Matthew N. Svalina",
      "id": "A5032694568",
      "orcid": "https://orcid.org/0000-0001-9919-9053",
      "institutions": [
        {
          "id": "I4210137443",
          "display_name": "Children's Cancer Therapy Development Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Matthew N. Svalina"
    },
    {
      "display_name": "Teagan P. Settelmeyer",
      "id": "A5057679544",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210137443",
          "display_name": "Children's Cancer Therapy Development Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Teagan P. Settelmeyer"
    },
    {
      "display_name": "Megan M. Cleary",
      "id": "A5062730079",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210137443",
          "display_name": "Children's Cancer Therapy Development Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Megan M. Cleary"
    },
    {
      "display_name": "Noah Berlow",
      "id": "A5089263262",
      "orcid": "https://orcid.org/0000-0001-8666-3152",
      "institutions": [
        {
          "id": "I4210137443",
          "display_name": "Children's Cancer Therapy Development Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Noah E. Berlow"
    },
    {
      "display_name": "Susan Airhart",
      "id": "A5059368484",
      "orcid": "https://orcid.org/0000-0001-7040-1238",
      "institutions": [
        {
          "id": "I4210115256",
          "display_name": "Jackson Laboratory",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Susan D. Airhart"
    },
    {
      "display_name": "Sunny Xiang",
      "id": "A5017106394",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210115256",
          "display_name": "Jackson Laboratory",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Sunny Xiang"
    },
    {
      "display_name": "James Keck",
      "id": "A5033226354",
      "orcid": "https://orcid.org/0000-0002-6835-5671",
      "institutions": [
        {
          "id": "I4210115256",
          "display_name": "Jackson Laboratory",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "James Keck"
    },
    {
      "display_name": "James B. Hayden",
      "id": "A5078882300",
      "orcid": null,
      "institutions": [
        {
          "id": "I165690674",
          "display_name": "Oregon Health & Science University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "James B. Hayden"
    },
    {
      "display_name": "Jack F. Shern",
      "id": "A5003760804",
      "orcid": "https://orcid.org/0000-0001-5579-7625",
      "institutions": [
        {
          "id": "I1299303238",
          "display_name": "National Institutes of Health",
          "country_code": "US",
          "type": "government"
        },
        {
          "id": "I4210149717",
          "display_name": "Center for Cancer Research",
          "country_code": "US",
          "type": "facility"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jack F. Shern"
    },
    {
      "display_name": "Atiya Mansoor",
      "id": "A5102896960",
      "orcid": "https://orcid.org/0000-0003-3371-0634",
      "institutions": [
        {
          "id": "I165690674",
          "display_name": "Oregon Health & Science University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Atiya Mansoor"
    },
    {
      "display_name": "Melvin Lathara",
      "id": "A5089889303",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210122755",
          "display_name": "Automatic Data Processing (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Melvin Lathara"
    },
    {
      "display_name": "Ganapati Srinivasa",
      "id": "A5053814182",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210122755",
          "display_name": "Automatic Data Processing (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ganapati Srinivasa"
    },
    {
      "display_name": "David M. Langenau",
      "id": "A5001440469",
      "orcid": "https://orcid.org/0000-0001-6664-8318",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I4210157861",
          "display_name": "Harvard Stem Cell Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David M. Langenau"
    },
    {
      "display_name": "Charles Keller",
      "id": "A5009653245",
      "orcid": "https://orcid.org/0000-0003-2505-7487",
      "institutions": [
        {
          "id": "I4210137443",
          "display_name": "Children's Cancer Therapy Development Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Charles Keller"
    }
  ],
  "publication_year": 2017,
  "publication_date": "2017-06-16",
  "type": "article",
  "cited_by_count": 17,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S126644158",
    "display_name": "Oncotarget",
    "issn_l": "1949-2553",
    "issn": [
      "1949-2553"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316297"
  },
  "volume": "8",
  "issue": "38",
  "first_page": "62976",
  "last_page": "62983",
  "open_access": {
    "is_oa": true,
    "oa_status": "gold",
    "oa_url": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=18520&path%5B%5D=59536",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C2780844630",
      "display_name": "Rhabdomyosarcoma",
      "level": 3,
      "score": 0.7255968
    },
    {
      "id": "C2776522094",
      "display_name": "Alveolar rhabdomyosarcoma",
      "level": 4,
      "score": 0.65029246
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.6113609
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.5151626
    },
    {
      "id": "C74909509",
      "display_name": "Gerontology",
      "level": 1,
      "score": 0.4486216
    },
    {
      "id": "C182996813",
      "display_name": "GSK-3",
      "level": 3,
      "score": 0.41471574
    },
    {
      "id": "C2778256501",
      "display_name": "Sarcoma",
      "level": 2,
      "score": 0.41052318
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.3495217
    },
    {
      "id": "C142724271",
      "display_name": "Pathology",
      "level": 1,
      "score": 0.3337394
    },
    {
      "id": "C184235292",
      "display_name": "Kinase",
      "level": 2,
      "score": 0.3310923
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.32423896
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.19330883
    },
    {
      "id": "C54355233",
      "display_name": "Genetics",
      "level": 1,
      "score": 0.13207096
    }
  ],
  "topics": [
    {
      "id": "T10253",
      "display_name": "Sarcoma Diagnosis and Treatment",
      "score": 0.9998
    },
    {
      "id": "T13157",
      "display_name": "Cancer-related gene regulation",
      "score": 0.9853
    },
    {
      "id": "T12140",
      "display_name": "Renal and related cancers",
      "score": 0.9844
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.18632/oncotarget.18520",
  "pdf_url": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=18520&path%5B%5D=59536",
  "retrieved_date": "2025-07-30T14:49:48.375084",
  "source_database": "OpenAlex"
}